Biotech

Avita Medical Announces Completion of Enrollment in ReCell(R) Trial for Vitiligo

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ...

Prima BioMed to Present at the 15th Annual Rodman & Renshaw Global Investment Conference

SYDNEY, AUSTRALIA: ...

Cytovance Biologics to Receive Metro 50 Award

OKLAHOMA CITY, OK: ...

Aragon Pharmaceuticals, Inc. Announces Closing of Its Acquisition by Johnson & Johnson

SAN DIEGO, CA: Seragon Pharmaceuticals Inc. Launched, Focused on Selective Estrogen Receptor Degrader Platform (SERD) ...

Critical Outcome Technologies Inc. Completes Financing

LONDON, ONTARIO: ...

Intrinsik Acquires McDaniel Lambert

TORONTO, ONTARIO and VENICE BEACH, CALIFORNIA: ...

ProMetic Reports Its Second Quarter 2013 Highlights and Financial Results

LAVAL, QUEBEC: - Plasma-derived Orphan Drug Plasminogen and Alpha1-Antitrypsin (AAT) development milestones achieved - cGMP plasma purification facility launch on schedule to enable orphan drugs IND filings - PBI-40 ...

CytoSorbents to Host Shareholder Update Conference on Wednesday, August 21st at 4:15 p.m. Eastern

MONMOUTH JUNCTION, NJ: ...

Arch Biopartners Joins the Life Sciences Canadian Technology Accelerator in San Francisco

TORONTO, ONTARIO: ...

Prima BioMed's "CANVAS" Clinical Trial Approved to Start in Korea

SYDNEY, AUSTRALIA: ...